🔗 Share this article Patients Coming Off Anti-Obesity Injections Gain Back Pounds at a Quadrupled Rate Than Dieters Weight management often requires ongoing approaches. New research reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop conventional lifestyle plans. Published data in a prominent health publication shows that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation. "Users purchasing such medications need to be informed of the danger of fast weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb. This pace of regain implies a return to original weight in about a year and a half. Analyzing Approaches The study, which reviewed dozens of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with older methods. Scientists note that people who shed pounds through dieting generally experience a slower creep back—around 100 grams monthly—once they finish. Understanding the Rapid Rebound Nutrition scientists suggest the mechanism of the drugs explains the amplified regain. GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Long-term administration of GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist. "Discontinuation of this hormone supplement results in hunger is uncontrolled, making excessive eating far more likely." An Ongoing Issue? The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes. Professionals argue that, given the significant potential of weight regain, the treatment might need to be ongoing. This view is reinforced by pharmaceutical companies, who note that the results "highlight the chronic nature of obesity," similar to managing diseases like hypertension. User Experiences People who have come off the jabs report a sudden resurgence of appetite. "It was like something flipping and I was suddenly starving," described an individual. The struggle is exacerbated if patients have not developed permanent dietary or behavioural modifications during therapy. Growing Use Survey data indicate that millions of adults in the UK have tried these injections in the past year, with demand being substantial. Use is higher among females compared to males. The middle-aged demographic shows the highest level of interest. Many access the medications through private healthcare rather than the NHS. In conclusion, researchers stress that while the jabs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on combined lifestyle changes.
Weight management often requires ongoing approaches. New research reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop conventional lifestyle plans. Published data in a prominent health publication shows that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation. "Users purchasing such medications need to be informed of the danger of fast weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb. This pace of regain implies a return to original weight in about a year and a half. Analyzing Approaches The study, which reviewed dozens of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with older methods. Scientists note that people who shed pounds through dieting generally experience a slower creep back—around 100 grams monthly—once they finish. Understanding the Rapid Rebound Nutrition scientists suggest the mechanism of the drugs explains the amplified regain. GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Long-term administration of GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist. "Discontinuation of this hormone supplement results in hunger is uncontrolled, making excessive eating far more likely." An Ongoing Issue? The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes. Professionals argue that, given the significant potential of weight regain, the treatment might need to be ongoing. This view is reinforced by pharmaceutical companies, who note that the results "highlight the chronic nature of obesity," similar to managing diseases like hypertension. User Experiences People who have come off the jabs report a sudden resurgence of appetite. "It was like something flipping and I was suddenly starving," described an individual. The struggle is exacerbated if patients have not developed permanent dietary or behavioural modifications during therapy. Growing Use Survey data indicate that millions of adults in the UK have tried these injections in the past year, with demand being substantial. Use is higher among females compared to males. The middle-aged demographic shows the highest level of interest. Many access the medications through private healthcare rather than the NHS. In conclusion, researchers stress that while the jabs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on combined lifestyle changes.